Proteomic analysis on the antibacterial activity of a Ru(II) complex against Streptococcus pneumoniae

Journal of Proteomics

Volumn 115, Issue , 2015, Pages 107-116

  Yang, Xiao Yan ^a,b   Zhang, Liang ^a   Liu, Jie ^a   Li, Nan ^a   Yu, Guangchuang ^a   Cao, Kun ^a   Han, Junlong ^a   Zeng, Guandi ^a   Pan, Yunlong ^b   Sun, Xuesong ^a   He, Qing Yu ^a  

^a JINAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

Antibacterial activity; Proteomic profiling; Ru(II) complex; S. pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; HEAT SHOCK PROTEIN; IRON; MANGANESE; RUTHENIUM COMPLEX; UNCLASSIFIED DRUG; X 03; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; RUTHENIUM;

A549 CELL LINE; AMINO ACID METABOLISM; AMINOACYLATION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOINFORMATICS; CARBOHYDRATE METABOLISM; CARBOXYLATION; CATALYSIS; CELL METABOLISM; DNA REPLICATION; DNA TRANSCRIPTION; DOWN REGULATION; DRUG UPTAKE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GENE ONTOLOGY; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WST-1 ASSAY; CELL LINE; CHEMISTRY; METABOLISM;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL LINE; HUMANS; PROTEOMICS; RUTHENIUM; STREPTOCOCCUS PNEUMONIAE;

EID: 84920930053     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.11.018     Document Type: Article

References (33)

1. Zaidi A.K., Thaver D., Ali S.A., Khan T.A. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009, 28:S10-S18.
2. Mitchell T.J. Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol 2000, 151:413-419.
3. Dwyer F.P., Gyarfas E.C., Rogers W.P., Koch J.H. Biological activity of complex ions. Nature 1952, 170:190-191.
4. Dyson P.J., Sava G. Metal-based antitumour drugs in the post genomic era. Dalton Trans 2006, 1929-1933.
5. Gianferrara T., Bratsos I., Alessio E. A categorization of metal anticancer compounds based on their mode of action. Dalton Trans 2009, 7588-7598.
6. Lentz F., Drescher A., Lindauer A., Henke M., Hilger R.A., Hartinger C.G., et al. Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study. Anticancer Drugs 2009, 20:97-103.
7. Sava G., Capozzi I., Clerici K., Gagliardi G., Alessio E., Mestroni G. Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex. Clin Exp Metastasis 1998, 16:371-379.
8. Chen T.F., Mei W.J., Wong Y.S., Liu J., Liu Y.N., Xie H.S., et al. Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers. Medchemcomm 2010, 1:73-75.
9. Institute CaLS Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement M100-S22 2012, CLSI, Wayne, PA, USA.
10. McDevitt C.A., Ogunniyi A.D., Valkov E., Lawrence M.C., Kobe B., McEwan A.G., et al. A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog 2011, 7:e1002357.
11. Wang Y., Cheung Y.H., Yang Z., Chiu J.F., Che C.M., He Q.Y. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 2006, 6:2422-2432.
12. Sun X., Ge F., Xiao C.L., Yin X.F., Ge R., Zhang L.H., et al. Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. J Proteome Res 2010, 9:275-282.
13. Sun X., Yang X.Y., Yin X.F., Yu G., Xiao C.L., He X., et al. Proteomic analysis of membrane proteins from Streptococcus pneumoniae with multiple separation methods plus high accuracy mass spectrometry. OMICS 2011, 15:683-694.
14. Gupta R., Shah P., Swiatlo E. Differential gene expression in Streptococcus pneumoniae in response to various iron sources. Microb Pathog 2009, 47:101-109.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
16. Chua A.C., Graham R.M., Trinder D., Olynyk J.K. The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 2007, 44:413-459.
17. Ratledge C. Iron metabolism and infection. Food Nutr Bull 2007, 28:S515-S523.
18. Andrews S.C., Robinson A.K., Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 2003, 27:215-237.
19. Tsou C.C., Chiang-Ni C., Lin Y.S., Chuang W.J., Lin M.T., Liu C.C., et al. An iron-binding protein, Dpr, decreases hydrogen peroxide stress and protects Streptococcus pyogenes against multiple stresses. Infect Immun 2008, 76:4038-4045.
20. Girinathan B.P., Braun S.E., Govind R. Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2. Microbiology 2014, 160:47-55.
21. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008, 10:179-206.
22. Cronan J.E., Waldrop G.L. Multi-subunit acetyl-CoA carboxylases. Prog Lipid Res 2002, 41:407-435.
23. Zhang Y., Cronan J.E. Transcriptional analysis of essential genes of the Escherichia coli fatty acid biosynthesis gene cluster by functional replacement with the analogous Salmonella typhimurium gene cluster. J Bacteriol 1998, 180:3295-3303.
24. Marrakchi H., Dewolf W.E., Quinn C., West J., Polizzi B.J., So C.Y., et al. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). Biochem J 2003, 370:1055-1062.
25. Zhang Q., Yu C., Min J., Wang Y., He J., Yu Z. Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening. J Mol Model 2011, 17:1483-1492.
26. Rock C.O., Cronan J.E. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim Biophys Acta 1996, 1302:1-16.
27. Heath R.J. Bacterial fatty-acid biosynthesis: an antibacterial drug target waiting to be exploited. Drug Discov Today 2001, 6:715.
28. Hartl F.U. Molecular chaperones in cellular protein folding. Nature 1996, 381:571-579.
29. Ang D., Georgopoulos C. The heat-shock-regulated grpE gene of Escherichia coli is required for bacterial growth at all temperatures but is dispensable in certain mutant backgrounds. J Bacteriol 1989, 171:2748-2755.
30. Murakami J., Terao Y., Morisaki I., Hamada S., Kawabata S. Group A streptococcus adheres to pharyngeal epithelial cells with salivary proline-rich proteins via GrpE chaperone protein. J Biol Chem 2012, 287:22266-22275.
31. Zhou Y., Chen W.N. iTRAQ-coupled 2-D LC-MS/MS analysis of cytoplasmic protein profile in Escherichia coli incubated with apidaecin IB. J Proteomics 2011, 75:511-516.
32. Campbell J.W., Cronan J.E. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 2001, 55:305-332.
33. Bergmann S., Rohde M., Chhatwal G.S., Hammerschmidt S. alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol 2001, 40:1273-1287.